These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 4744987

  • 1. [Clinical experiences with an oral, long-term neuroleptic agent: penfluridol].
    Floru L, Zurborn R.
    Med Welt; 1973 Apr 13; 24(15):600-3. PubMed ID: 4744987
    [No Abstract] [Full Text] [Related]

  • 2. [Long-acting neuroleptics. 3. Pilot study of penfluridol (R16341): psychometric data].
    Mormont C.
    Acta Psychiatr Belg; 1972 Sep 13; 72(5):595-601. PubMed ID: 4669431
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A, Pineau R, Jus K, Villeneuve A, Gautier J, Pires P, Drolet A, Cote M, Villeneuve R.
    Curr Ther Res Clin Exp; 1974 Oct 13; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract] [Full Text] [Related]

  • 5. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ.
    Psychiatr Neurol Neurochir; 1973 Oct 13; 76(2):83-92. PubMed ID: 4573494
    [No Abstract] [Full Text] [Related]

  • 6. Safety evaluation of penfluridol, a new long-acting oral antipsychotic agent.
    Ota KY, Kurland AA, Slotnick VB.
    J Clin Pharmacol; 1974 Apr 13; 14(4):202-9. PubMed ID: 4595986
    [No Abstract] [Full Text] [Related]

  • 7. The use of an oral long-acting anti-psychotic agent, penfluridol, in schizophrenia.
    White AC, Sims AC.
    Curr Med Res Opin; 1974 Apr 13; 2(1):23-6. PubMed ID: 4841811
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical trial of a neuroleptic with prolonged action (fluspirilene)].
    De Francisco CP, Nieto Gómez D, Castilla J, Torres A, Avalos C.
    Actas Luso Esp Neurol Psiquiatr; 1971 Apr 13; 30(3):123-8. PubMed ID: 5145187
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interaction between neuroleptic therapy and sociotherapeutic approach an investigation with penfluorid and haloperidol.
    van Lommel R, Dom R, Baro F.
    Act Nerv Super (Praha); 1974 Mar 13; 16(1):75-6. PubMed ID: 4454953
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical evaluation of penfluridol--a neuroleptic with prolonged action (oral administration) in the treatment of schizophrenic psychoses].
    Majczak A, Wielosz M, Grzywa A, Kornacki L, Nagay J, Jasińska M.
    Psychiatr Pol; 1978 Mar 13; 12(5-6):555-62. PubMed ID: 724849
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J, Woggon B.
    Arzneimittelforschung; 1975 Feb 13; 25(2):267-70. PubMed ID: 1091272
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.